CAHNEUTRAL

EV/EBITDA

14.8x

Higher than 52% of Healthcare sector peers

Updated 79h ago

Sector Performance

52th percentile

CAH

14.8x

Sector Median

14.4x

Sector Avg

24.8x

📊

Deep Analysis

Cardinal Health's EV/EBITDA currently stands at 14.8x, meaning the company's total enterprise value is 14.8 times its earnings before interest, taxes, depreciation, and amortization — a valuation measure that helps investors compare companies regardless of debt or tax differences.

This value sits exactly at the healthcare sector median of 14.8x, placing the stock at the 50th percentile among its peers, neither cheap nor expensive relative to the group. While the year-over-year change is not available, the most recent data shows a 3.4% quarter-over-quarter increase from 14.3x to 14.8x. A valuation level that matches the sector median combined with a small upward trend suggests limited mispricing and no clear risk or opportunity from this metric alone. This neutral positioning directly supports the overall NEUTRAL verdict, as the metric neither overvalues nor undervalues the stock compared to its industry.

Frequently Asked Questions

What does the EV/EBITDA tell investors about CAH?

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.

How is the EV/EBITDA calculated?

EV/EBITDA is calculated as: Enterprise Value / EBITDA.

How does CAH's EV/EBITDA compare to its sector?

CAH's EV/EBITDA of 14.8x compares to a Healthcare sector median of 14.4x, placing it in the 52th percentile.

Who are CAH's closest peers by EV/EBITDA?

The closest Healthcare peers by EV/EBITDA include: AMGN (14.0x), DGX (13.6x), ALGN (13.5x), AZN (15.9x), BIO (17.3x).

The Formula

Enterprise Value / EBITDA

Why It Matters

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.